AAPLLoadingMSFTLoadingNVDALoadingGOOGLLoadingAMZNLoadingMETALoadingTSLALoadingAMDLoadingNFLXLoadingCOINLoadingPYPLLoadingSPYLoadingQQQLoadingIWMLoadingJPMLoadingVLoadingDISLoadingKOLoadingJNJLoadingNKELoadingXOMLoadingASMLLoading
FreeMETA4 min read

The ad business is fine, which is the problem

It traded at 736.60 this morning, +0.70% on the session. This is a company I find genuinely hard to hold a view on, and I would rather say that than manufacture conviction.

META
Delayed

Two businesses, one ticker

There is an advertising business that is mature, extremely profitable, and better run than its critics allow. And there is a long-horizon investment programme consuming a meaningful share of what the first one earns.

Owning the share means owning both. Most analysis picks the one that suits the argument and quietly ignores the other.

The honest difficulty

You can value the ad business. It has history, comparable companies, and a demand cycle you can reason about. The other side has no revenue to speak of, no reliable comparables, and a payoff that is either enormous or nothing.

So the valuation question is not "what is this worth". It is "what am I paying for the option, and can I bear it being worth zero".

  • Strip out the investment spending and the core looks reasonably priced
  • Include it at cost and the whole thing looks expensive
  • Include it at management's ambition and it looks cheap

Three defensible methods, three different answers. That is not a model, that is a mood.

Why I am flat

When my valuation range is wider than the potential return, the position size that makes sense is zero.

I do not have an edge in predicting whether the long-horizon bet works. Nobody writing about it does, including the people who sound most certain. What I can say is that the core business is performing, which means the option is being funded rather than borrowed for. That is meaningfully better than the alternative.

What would get me involved

Either the investment programme starting to show revenue I can actually measure, or the market pricing the share as though the core alone were the whole company. The first is a better business. The second is a better price. Either would do.

The author holds no position in the instruments discussed. Opinion. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Past performance is not a reliable indicator of future results.

Comments

0 comments
Sign in to comment.

No comments yet

Be the first to weigh in.